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1 Abstract 
 
2 Objective: To evaluate the reported fatigue levels and gait deficits in Multiple Sclerosis (MS) 
 
3 patients to determine the relationships that may exist between fatigue in MS patients and 
 
4 alterations in gait mechanics. 
 
5 Design: Cross-sectional 
 
6 Setting: Biomechanics laboratory 
 
7 Participants: Subjects with MS (n = 32) and age- and sex-matched controls (n = 30). 
 
8 Interventions: None 
 
9 Main Outcome Measures: Fatigue Severity Scale (FSS), Modified Fatigue Index Scale (MFIS), 
 
10 and shortform SF-36 to assess fatigue and general health. Biomechanical gait analysis was 
 
11 performed to measure peak joint torques and powers in the sagittal plane at the ankle, knee, and 
 
12 hip. Correlations were performed between fatigue measures and degree of deficit within each MS 
 
13 patient for each joint torque and power measure. 
 
14 Results: FSS was significantly correlated with deficits in ankle power generation at late stance 
 
15 and walking velocity.  MFIS was significantly correlated with deficits in peak knee extensor 
 
16 torque and in knee power absorption at early stance.  SF-36 subscales were correlated with 
 
17 several of the joint torque and power variables. 
 
18 Conclusions: subjective fatigue rating scales alone should not be used as an indicator of motor 
 
19 disability or of disease progression as it affects the walking performance of the MS patients 
 
20 Key words: joint torque, joint power, general health, neurological disease 
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21 Introduction 
 
22 Fatigue is one of the most common symptoms of multiple sclerosis (MS). It is reported 
 
23 by up to 90% of patients and is described as an increased weakness with exercise or as the day 
 
24 progresses, as an abnormal constant and persistent sense of tiredness, or as fatigable weakness 
 
25 exacerbated by activity or heat 
1, 23
. Measurement of fatigue in MS patients is based primarily on 
 
26 the patient’s own reports, and as a result, the measures are inherently subjective. Fatigue ratings 
 
27 in MS patients may be affected by the individual’s performance self efficacy and altered sensory 
 
28 input during activity. Also, ratings may be affected if an observer rates the fatigue based on 
 
29 reports of decreased effort due to impaired motor control capabilities
4
. 
 
30 Because fatigue is a subjectively reported symptom, there are currently no tests or 
 
31 objective signs allowing the clinician to quantify its severity outside of fatigue related 
 
32 questionnaires 
5
. Studies to investigate relationships between fatigue scores have reported weak 
 
33 correlations and noted that fatigue is a multi-factorial symptom which may not be fully explained 
 
34 by one fatigue scale or another1, 2. Additionally, changes in fatigue ratings do not correlate with 
 
35 changes in walking performance which led researchers to suggest monitoring reports of fatigue 
 
36 with more objective measures
6
. Lack of correlation between fatigue ratings and walking 
 
37 performance may exist because self-reported fatigue scales rely on subjective reporting by 
 
38 patients and therefore cannot differentiate an inability to generate or maintain voluntary force 
 
39 from an unwillingness to do so4. 
 
40 MS fatigue symptoms are likely due to ‘central fatigue’ which indicates a problem with 
 
41 the neural drive to sustain muscle force4. Neural drive is also required to facilitate walking and 
 
42 thus is feasible to expect fatigue to be reflected as alterations in walking mechanics when MS 
 
43 patients are compared to healthy controls. This association between specific reports of fatigue 
 
44 and the gait mechanics of patients with MS has not previously been investigated. 
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45 The purpose of this study was to evaluate both the reported fatigue levels in MS patients 
 
46 and these patients’ deficits in gait mechanics to determine whether relationships exist between 
 
47 fatigue in MS patients and alterations in gait mechanics. It was hypothesized that since both 
 
48 fatigue in MS patients and neural control of gait are mediated by supraspinal and spinal inputs 
4,
 
 
49 7-9, there would be a significant relationship between reported fatigue levels and the alterations in 
 
50 gait mechanics of MS patients. Additionally, alterations in walking mechanics could lead to 
 
51 increased metabolic cost and overall greater energy expenditure during walking 
10, 11
. Thus, 
 
52 persons with MS who have greater alterations in walking mechanics could have greater fatigue 
 
53 levels. In addition to fatigue measures, general health measures were also investigated and 
 
54 compared to gait measures to determine whether general health perceptions of MS patients are 
 
55 related to gait mechanics.  Because general health perceptions are likely influenced by fatigue 
 
56 levels, it was hypothesized that general health perceptions are also related to deficits in gait 
 
57 mechanics. 
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58 Methods 
 
59 Multiple Sclerosis patients. The study comprised of 32 MS patients and 30 age, weight, 
 
60 gender and height matched healthy controls. All participants were recruited by our clinicians at 
 
61 the University’s Medical Center Department of Neurology and through advertisements placed 
 
62 with the local chapter of the National Multiple Sclerosis Society. They provided informed 
 
63 consent in accordance with procedures approved by the University’s Medical Center Institutional 
 
64 Review Board. 
 
65 Inclusion criteria for patients with MS included cognitive competency to give informed 
 
66 consent as determined by our MS clinician (coauthor MF), age ranging from 19 years to 65 
 
67 years, an Expanded Disability Status Scale (EDSS) score 1 – 6.0 12. There was no requirement 
 
68 for MS disease type for inclusion in the study. Healthy controls were age 19 to 65 years and free 
 
69 of any neurological, orthopaedic, or other co-morbid condition which could affect walking 
 
70 mechanics. Exclusion criteria for both patient with MS and healthy controls for the study 
 
71 included: inability to give informed consent, pregnancy or breastfeeding or within 3 months post 
 
72 partum at the initiation of the study, any other neurological or vestibular disorder, and any other 
 
73 co-morbid conditions which would affect gait mechanics.  Controls were recruited from family 
 
74 members of MS subjects and through the community to match the overall MS group 
 
75 characteristics but were not matched to individual subjects. 
 
76 Data Collection Protocol 
 
77 In order to evaluate gait mechanics, joint torques and powers from the lower extremities 
 
78 were used to evaluate the overall joint muscular contributions and their responses during 
 
79 locomotion. Joint torques and powers have been used successfully to classify gait mechanics in 
 
80 the elderly and in patients with osteoarthritis, total joint replacement, and anterior cruciate 
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81 ligament deficiency 13-16 to make surgical decisions 17, and to evaluate treatment outcomes in 
 
82 pathological populations 
18, 19
. For all data collections, the subjects (patients and controls) 
 
83 arrived at the laboratory where informed consent was obtained. Next, anthropometric data of the 
 
84 lower extremities was measured and reflective markers were placed according to anatomical 
 
85 location 20. Figure 1 shows the marker set-up from the frontal plane only. Subjects walked 
 
86 through 10 meter walk-way equipped with an embedded force platform (Kistler 9281B, Kistler 
 
87 Instrumentation Corporation, Amhurst, NY) and surrounded with an 8 camera Motion Analysis 
 
88 system (Eagle system, Motion Analysis Corp., Santa Rosa, CA). Figure 2 shows a subject 
 
89 walking with a foot striking the force platform. The subject walked through the walkway from 
 
90 the determined starting position while 
 
91 INSERT FIGURE 1 AND FIGURE 2 
 
92 real-time marker position (60 Hz) and force platform (600 Hz) data was collected 
 
93 simultaneously. Once the trial was completed, the MS patient rested for at least one minute. The 
 
94 same process was then repeated at least four more times to obtain five good trials with the 
 
95 subject’s footfall landing completely within the force plate without altering the stride. After five 
 
96 successful trials, the other leg was collected using the same process. Participants typically 
 
97 needed to complete a total of 15 walking trials in order to obtain 5 good trials on each side. 
 
98 Finally, the MS patients completed two fatigue specific questionnaires and a general health 
 
99 survey, the SF-36 questionnaire. These are described below. 
 
100 Qualitative measures 
 
101 Fatigue Severity Scale. The FSS is a method of evaluating fatigue in MS patients and in 
 
102 other conditions including chronic fatigue immune dysfunction syndrome and systemic lupus 
 
103 erythmatosis. The FSS is designed to differentiate fatigue from clinical depression, since both 
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104 share some of the same symptoms. The FSS questionnaire is comprised of nine statements 
 
105 related to the patients’ subjective perception of fatigue and its consequences on everyday 
 
106 activities. Patients are asked to rate their level of agreement (toward seven) or disagreement 
 
107 
 
108 
(toward zero) with the nine statements. The FSS has been validated for use with MS patients 
where the scale demonstrated high internal consistency with a Cronbach’s alpha of 0.81 21. 
109 Modified Fatigue Impact Scale. The MFIS is a modified form of the Fatigue Impact Scale 
 
110 based on items derived from interviews with MS patients. The scale assesses the effect of fatigue 
 
111 
 
112 
in terms of physical, cognitive, and psychosocial functioning with a 21-item questionnaire. The 
MFIS has been validated for use with MS patients by Kos et al 
22 
who found the overall 
113 Cronbach’s alpha was 0.9223, 0.8813 for the physical, 0.9219 for the cognitive and 0.6496 for 
 
114 the psychosocial subscale. 
 
115 Short form SF-36. Eight health domains are assessed with the SF-36: Physical Function, 
 
116 limitation due to Physical Health, limitation due to Emotional Problems, Energy, Mental Health, 
 
117 
 
118 
 
119 
Bodily Pain, General Health, and Social Function. The SF-36 has been used extensively to 
evaluate and differentiate between groups of varying health status 
23, 24 
and has previously been 
used with MS patients 
25, 26
. 
120 Quantitative Measures 
 
121 Joint Torques & Powers. During post processing, a low-pass second order Butterworth 
 
122 digital filter with a 7 Hz cutoff frequency was used to smooth the marker trajectories. 
 
123 
 
124 
Subsequently, the joint angles were calculated for the sagittal plane during the stance phase of 
walking based on the methods of Vaughan et al 
27 
and Nigg et al 
28
. Joint torques were then 
125 
 
126 
calculated from the joint angles of the lower limb segments and the simultaneous ground reaction 
forces produced based on inverse dynamics 
29
. Joint powers were calculated based on the 
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127 resultant joint torques and the angular velocities of the limb segments. Calculation of joint 
 
128 torques and powers was accomplished using custom made laboratory software generated in 
 
129 Matlab (The MathWorks, Inc., Natick, MA). 
 
130 The peak values for joint extensor and flexor torque, and joint power absorption and 
 
131 
 
132 
generation (Figures 3 and 4) were identified for the ankle, knee and hip joints during the stance 
phase according to other gait studies on joint kinetics 
13, 30-32
. To identify the difference between 
133 MS patients and controls for the joint torques and powers, the value for each peak joint torque 
 
134 and peak joint power variable (average from 5 trials) for each MS patient was subtracted from 
 
135 the corresponding average value of the same variable from the healthy control group (Table 3). 
 
136 For example, for each MS subject, the differenced joint torque and joint power variables were 
 
137 calculated as: 
 
138 d_APT = APTcontrol mean – APTMS subject 
 
139 Because control subjects were recruited as a group and not matched to individual MS subjects, 
 
140 this methodology allowed for identification of the differences between MS patients and the entire 
 
141 control group rather than single control subjects. 
 
142 INSERT FIGURE 3 HERE 
 
143 INSERT FIGURE 4 HERE 
 
144 Statistical Analysis 
 
145 A sample of 30 MS patients and 30 matched controls yielded 80% power to detect an 
 
146 effect size of 0.9 for differences in gait variables between the two groups. Independent t-tests 
 
147 were used to compare demographic data for patients with MS to healthy controls. Pearson 
 
148 correlations were performed between the scores for the FSS, MFIS, each of the eight SF-36 
 
149 domains and each of the differenced joint torque and power parameters. All data was assessed 
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150 for normality (Q-Q plots) and found to be normally distributed. Analyses were performed using 
 
151 SPSS 16.0 statistical software (SPSS Inc, Chicago, IL) with alpha equal with 0.05. Due to the 
 
152 
 
153 
exploratory nature of this study, no adjustments were made for multiple comparisons. 
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154 Results 
 
155 A total of 32 patients with MS and 30 healthy controls were included. The MS group and 
 
156 healthy controls did not significantly differ in terms of age and mass. None of patients with MS 
 
157 experienced a relapse of symptoms within 3 months of participating in the gait analysis. All of 
 
158 the MS subjects were on disease modifying, but not on symptom modifying therapies. The mean 
 
159 EDSS score for the MS group was 2.6 ± 0.7 which indicates a relatively mild level of motor 
 
160 disability. 
 
161 INSERT TABLE 1 HERE 
 
162 The mean scores for the Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale 
 
163 (MFIS) and for each subscale of the SF-36 are listed in Table 2. 
 
164 INSERT TABLE 2 HERE 
 
165 The FSS showed a significant relationship only with walking velocity (Table 3) and peak 
 
166 ankle power generation (A2) (Table 4). The MFIS showed a significant relationship only with 
 
167 peak knee extensor torque (Table 3) and the peak knee power absorption (K1) (Table 4). The SF- 
 
168 36 Physical Function subscale revealed a significant relationship with several parameters from 
 
169 the joint torques (4 out of 6; Table 3) and joint powers (6 out of 8; Table 4). The Limitation due 
 
170 to Emotional Problems and Social Function subscales each showed a significant relationship 
 
171 with one joint torque (Table 3) and one joint power parameter (Table 4). The Limitation due to 
 
172 Physical Function subscale showed a significant relationship with walking velocity (Table 3) and 
 
173 with one joint power parameter (Table 4). The Energy subscale showed a significant relationship 
 
174 with one joint power parameter (Table 4). The Bodily Pain subscale showed a significant 
 
175 relationship with walking velocity (Table 3), two joint torque parameters (2 out of 6; Table 3) 
 
176 and three joint power parameters (3 out of 8; Table 4). 
 
177 INSERT TABLES 3 & 4 HERE 
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178 Importantly, all the significant relationships between the quantitative gait measures (joint 
 
179 
 
180 
torques and powers) and the fatigue scales (FSS and MFIS) were small or medium (0.1 to 0.3 
and 0.3 to 0.5, respectively) 
33
. In contrast, the SF-36 physical function subscale revealed large 
181 correlations (0.5 to 1.0) with walking velocity and with the joint torque and joint power 
 
182 
 
183 
parameters (Table 3 and 4). 
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184 Discussion 
 
185 This study outlines the relationship between reported fatigue levels and the deficits in 
 
186 joint torques and powers during overground walking in MS patients. The FSS, which specifically 
 
187 evaluates fatigue levels independent of depression, showed only two significant relationships 
 
188 out of 15 (13.3%), indicating a limited relationship with the changes that occur in the gait 
 
189 mechanics of patients with MS. The MFIS, which is an MS patient specific fatigue measure, 
 
190 showed similar results with only two significant relationships out of 15 (13.3%). It was 
 
191 hypothesized that fatigue and gait mechanics would reveal significant relationships because both 
 
192 
 
193 
fatigue in MS patients and gait control. Because both gait and fatigue are affected by central 
neural drive
4, 7, 9
, it is expected that any alterations in gait mechanics would likely contribute to 
194 fatigue. This hypothesis was shown to be only partially true with respect to the utilized fatigue 
 
195 scales. With respect to SF-36, the Physical Function subscale and the Bodily Pain subscale both 
 
196 showed relationships with the gait mechanics of patients with MS with 11 out of 15 (73.3%) and 
 
197 6 out of 15 (40.0%) correlations, respectively, being significant. The larger number of significant 
 
198 relationships with gait mechanics and the SF-36 subscales is partially in agreement with the 
 
199 original hypothesis that general health perceptions would be related to gait deficit measures. 
 
200 The lack of correlations between fatigue questionnaires (FSS and MFIS) and measures of 
 
201 gait mechanics indicate that the use of fatigue questionnaires to infer information regarding MS 
 
202 patient’s functional capability may be inappropriate. The SF-36 subscales focus more on specific 
 
203 function areas and show stronger relationship with gait mechanics. Thus, we believe that it may 
 
204 be possible to better represent the relationship between fatigue in MS patients and their gait 
 
205 mechanics by expanding the fatigue questionnaires to incorporate the effects of fatigue on 
 
206 specific areas of physical function as the SF-36 does. 
Fatigue and gait mechanics in MS patients  
 
 
207 The FSS was significantly and positively related with walking velocity (Table 3) and 
 
208 with the joint power measure A2 (Table 4). Overall, the FSS focuses on the perception of fatigue 
 
209 and its consequences on everyday activities, so the results indicate that the worse the MS 
 
210 patient’s perception of fatigue was, the larger the differences in walking velocity and in power 
 
211 generation at the ankle (A2) during late stance between the patients and the healthy controls. The 
 
212 decrements in power generation at the ankle (A2) during late stance indicate that the MS patients 
 
213 have difficulty propelling the trunk and the leg into the swing phase and indicate that the ankle 
 
214 
 
215 
plantarflexors (soleus and gastrocnemius) are not providing sufficient power to accelerate the 
trunk which would result in slower walking velocity 
34
. The significant relationship between FSS 
216 and walking velocity decrements in MS patients indicate that FSS is related primarily with the 
 
217 mechanisms related to forward progression during walking.  Decreased walking velocity and 
 
218 
 
219 
 
220 
decreased capability to maintain forward progression during walking could result in increased 
energy expenditure during walking 
35 
and would likely affect performance on everyday activities 
34, 36
, causing increased overall fatigue, thus demonstrating a relationship between A2 and FSS 
221 score. 
 
222 The MFIS, which outlines the effect of fatigue in terms of physical, cognitive, and 
 
223 psychosocial functioning, was correlated decreased power absorption at the knee (K1) and 
 
224 extensor torque at the knee (KET) during early stance phase.  The decreased power absorption at 
 
225 the knee (K1) and extensor torque at the knee (KET) indicate that MS patients have difficulty 
 
226 
 
227 
during weight acceptance in single stance and are not able to generate the necessary extensor 
activity to eccentrically absorb power at the knee (negative muscle) during early stance
35
.  Loss 
228 
 
229 
of the high efficiency negative work at the knee could result in increased metabolic energy 
expenditure during gait
35 
and a larger metabolic cost of walking for patients with MS. Because 
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230 MFIS shows a significant relationship with the amount of negative work being performed at the 
 
231 knee during early stance, we can speculate that the MFIS is related mostly with the overall 
 
232 energy expenditure of patients with MS during walking. 
 
233 MS patients may be likely to perceive fatigue levels as higher since their ability to 
 
234 maintain forward progression is diminished and overall metabolic cost is likely increased during 
 
235 walking. To maintain forward progression an increase in the frequency of muscle firing would be 
 
236 
 
237 
 
238 
necessary, but this could be difficult to maintain for an MS patient due to demyelination of nerve 
fiber and conduction block seen in structurally intact axons 
37
. This conduction block is proposed 
as the primary causation of fatigue in MS patients seen during voluntary effort 
4
.  The 
239 correlations between FSS, MFIS, and the specified joint power measures may be a reflection of 
 
240 the theorized primary causation of fatigue in MS patients. 
 
241 Finally, the SF-36 subscales for Physical Function and Bodily Pain, which measure 
 
242 overall perceptions of general health, both had negative correlations with joint parameters which 
 
243 indicate that as differences in the gait measures between MS patients and healthy controls 
 
244 increased, the perception of physical function capability decreased in MS patients and the 
 
245 
 
246 
perceptions of bodily pain increased in MS patients. These results are not surprising since Motl 
et al 
38
reported that worsening MS symptoms have a direct negative relationship with self- 
247 efficacy and physical activity; hence any changes in actual physical capability levels (reflected 
 
248 here by joint torques and powers) would also be related to perception of physical function. The 
 
249 
 
250 
same investigators also reported that with worsening of symptoms, including an increase in 
bodily pain, there is a significant decrease in levels of physical activity and physical function
39
. 
251 Because these scales are significantly related with several of the gait measures, it is fair to report 
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252 that the SF-36 subscales are relatively successful in reflecting the motor disability level of MS 
 
253 patients. 
 
254 Because alterations in joint torques and powers would likely cause changes in energy 
 
255 expenditure during walking, it is likely that there is a relationship between gait measures and 
 
256 fatigue in persons with MS. However, this study showed limited correlations between the FSS 
 
257 and MFIS with gait measures. The SF-36 subscales showed more relationships with gait 
 
258 measures which may indicate that the SF-36 is a better measure of overall functional status in 
 
259 MS patients, however, a larger follow-up study would be needed to confirm these findings. The 
 
260 
 
261 
idea that fatigue specific questionnaires may not be the best tool to reflect physical disability 
level has also been reported by others 
6, 40, 41
.  These previously published findings combined 
262 with the findings of the current study indicate that subjective fatigue rating scales alone should 
 
263 not be used as an indicator of motor disability or of disease progression as it affects the walking 
 
264 performance of the MS patients.  Instead, more quantitative measures, such as gait analysis 
 
265 should be used to indicate the relationship between gait problems and fatigue in MS patients and 
 
266 to support clinical decision making. 
 
267 Limitations 
 
268 Several limitations exist in this study. First, it should be noted that we included only MS patients 
 
269 who were ambulatory in the study. Thus, the findings of this study, in terms of usefulness of 
 
270 fatigue scales to indicate functional status and disability, are generalizable only to MS patients 
 
271 who are ambulatory without bilateral aid (EDSS < 6.0). Second, the causes of gait dysfunction in 
 
272 patients with MS are likely multi-factorial and this study did not attempt to differentiate which 
 
273 disease mechanisms, i.e. spasticity, neuropathy, muscle weakness, were specifically related to 
 
274 measures of fatigue and general health. Finally, reported fatigue in MS patient is also multi- 
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275 factorial. Specific medication, sleep patterns, and overall lifestyle influences may affect reports 
 
276 of fatigue. By utilizing fatigue rating scales that are well established for use with patients who 
 
277 have MS, this study did not seek to specify the sources of reported fatigue but only the relative 
 
278 MS fatigue rating and whether those ratings were related to objective and reliable measures of 
 
279 walking performance. 
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1 Tables 
 
 
2 Table 1: Demographic information of study participants. P-value is indicated for independent t- 
3 test between groups. 
 
MS Patients Healthy Controls 
    (n = 32)   (n = 30)
 Sex 5 male, 27 female 8 male; 22 female 
Age 46.3 ± 10.8 yrs 41.4 ± 12.2 yrs p = 0.097 
EDSS 2.6 ± 0.7 - 
Height (cm) 165.0 ± 6.7 170.6 ± 11.2 p = 0.021 
Mass (kg) 79.9 ± 18.5 76.9 ± 18.5 p = 0.535 
4 
 
 
5 
Table  
6 Table 2: Averaged scores for each fatigue scale and for each component of the Medical 
7 Outcomes Short Form 36 Health Survey (SF-36) for MS patients. 
 
 
 
Questionnaire Scale 
Fatigue Severity 
MS patient score 
mean ± SD 
Scale 
4.6 ± 1.5 
Modified Fatigue 
Impact Scale 
SF-36 
 
42.3 ± 15.4 
Physical function 57.8 ± 23.6 
Limitation due to 
Physical Function 
Limitation due to 
Emotional Problems 
 
43.0 ± 36.1 
 
 
46.8 ± 43.0 
Energy 46.4 ± 22.5 
Mental Health 65.0 ± 22.0 
Social Function 61.9 ± 27.3 
Bodily Pain 65.4 ± 22.9 
  General Health 50.3 ± 20.6   
8 
 FSS *0.35 (.049) 0.22 0.31 0.30 0.09 0.26 0.02 
MFIS 0.34 0.20 0.14 *0.37 (.038) -0.03 0.16 -0.09 
SF-36        
Physical function *-0.70 (.000) *-0.54 (.002) *-0.51 (.003) *-0.69 (.000) -0.15 -0.22 *-0.39 (.029) 
Limitation due to        
Physical Function 
*-0.35 (.050)
 
-0.09 -0.09 -0.26 0.21 -0.070 -0.02 
Limitation due to 
motional Problems 
-0.11 0.04 -0.22 *-0.36 (.041) 0.32 -0.12 -0.16 
Energy 0.05 0.06 0.18 -0.13 0.23 -0.12 0.16 
Mental Health 0.13 0.04 0.12 -0.23 0.32 -0.06 0.31 
Social Function -0.15 -0.08 -0.08 *-0.37 (.038) 0.10 -0.01 0.05 
Bodily Pain *-0.46 (.008) *-0.37 (.037) -0.26 *-0.45 (.011) -0.15 -0.03 -0.13 
General Health -0.11 -0.100 -0.08 -0.13 0.07 -0.10 0.16 
 
 
9 Table 3: Correlation matrix between quantitative parameters of gait mechanics (joint torques) and the qualitative self- 
10 perceived measures of fatigue (Fatigue Severity Scale, Modified Fatigue Impact Scale) and functional status (SF-36) of MS 
11 patients. Pearson correlation values are reported. 
 
Qualitative Measure Quantitative Measure 
  d_Velocity d_ADT d_APT d_KET d_KFT d_HET d_HFT   
 
 
 
 
 
 
 
 
 
 
E 
 
 
 
 
 
 
 
12 SF-36: Medical Outcomes Survey Short Form 36 Health Survey. 
 
13 *Significant correlations (p -value). 
 
14 d_Velocity – difference in walking velocity; d_ADT - difference in Peak ankle dorsiflexion moment during early stance; d_APT - 
 
15 difference in Peak ankle plantarflexion moment during late stance; d_KFT - difference in Peak knee flexion moment during stance; 
 
16 d_KET - difference in Peak knee extension moment during stance; d_HFT - difference in Peak hip flexion moment during late stance; 
 
17 d_HET - difference in Peak hip extension moment during early stance. 
 FSS 0.25 0.42 (.010) 0.28 0.27 0.31 0.31 0.07 0.00 
MFIS 0.31 0.32 0.35 (.048) 0.33 0.11 0.21 0.07 0.10 
SF-36         
Physical function -0.38(.033) -0.69 (.000) -0.62 (.000) -0.42 (.017) -0.43 (.015) -0.11 -0.56(.001) 0.09 
Limitation due to         
Physical Function 
-0.10
 
-0.23 -0.24 -0.37 (.035) -0.29 -0.17 -0.10 -0.17 
Limitation due to 
motional Problems 
-0.11 -0.28 -0.29 -0.45 (.009) -0.19 -0.04 -0.28 -0.22 
Energy -0.09 -0.01 -0.08 -0.37 (.037) -0.15 -0.03 0.06 -0.24 
Mental Health -0.06 0.01 -0.11 -0.22 -0.02 -0.10 0.05 -0.04 
Social Function -0.18 -0.22 -0.34 -0.38 (.030) -0.24 -0.09 -0.12 -0.32 
Bodily Pain -0.32 -0.48 (.005) -0.50 (.003) -0.39 (.026) -0.14 -0.13 -0.27 0.14 
General Health -0.01 -0.20 -0.11 -0.04 -0.06 -0.15 -0.05 0.04 
 
 
18 Table 4: Correlation matrix between quantitative parameters of gait mechanics (joint powers) and the qualitative self- 
19 perceived measures of fatigue (Fatigue Severity Scale, Modified Fatigue Impact Scale) and functional status (SF-36) of MS 
20 patients. Pearson correlation values are reported. 
 
Qualitative Measure Quantitative Measure 
  d_A1 d_A2 d_K1 d_K2 d_K3 d_H1 d_H2 d_H3   
 
 
 
 
 
 
 
 
 
 
E 
 
 
 
 
 
 
 
21 SF-36: Medical Outcomes Survey Short Form 36 Health Survey. 
 
22 *Significant correlations (p -value). 
 
23 d_A1 - difference in Peak ankle power absorption in early stance; d_A2 - difference in Peak ankle power generation in late stance; 
 
24 d_K1 - difference in Peak knee power absorption in early stance; d_K2 - difference in Peak knee power generation in mid-stance; 
 
25 d_K3 - difference in Peak knee power absorption in late stance; d_H1 - difference in Peak hip power generation in early stance; d_H2 
 
26 - difference in Peak hip power absorption in late mid-stance; d_H3 - difference in Peak hip power generation in late stance. 
  
 
 
Figure 1: Marker set 
from the frontal plane 
Figure 2: A subject walking with one 
foot striking the force platform 
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Figure 3: Joint Torque figures which identify 
the gait variables used 
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